[Clinical evaluation of ceftriaxone in children]. 1984

I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi

Fundamental and clinical evaluation on ceftriaxone (Ro 13-9904, CTRX) was performed and the following results were obtained. As to bacteriological efficacy, bacteria were reduced in the case with S. panama bacteremia, while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis. The clinical efficacy was excellent in 2 cases and good in 3, the efficacy rate being 100%. No side effects were observed to require the withdrawal of CTRX.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
December 1984, The Japanese journal of antibiotics,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
January 1984, Clinical therapeutics,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
November 1984, The Japanese journal of antibiotics,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
July 1982, Antimicrobial agents and chemotherapy,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
September 1988, The Japanese journal of antibiotics,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
December 1984, The Japanese journal of antibiotics,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
November 1984, The Japanese journal of antibiotics,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
May 1986, Pathologie-biologie,
I Terashima, and S Uehara, and T Toba, and T Hayashi, and M Hoshi
January 1985, The Japanese journal of antibiotics,
Copied contents to your clipboard!